Login / Signup

Identifying pregnancies in insurance claims data: Methods and application to retinoid teratogenic surveillance.

Sarah C MacDonaldJacqueline M CohenAlice PanchaudThomas F McElrathKrista F HuybrechtsSonia Hernández-Díaz
Published in: Pharmacoepidemiology and drug safety (2019)
Administrative databases can complement risk evaluation and mitigation strategies (REMS) for known teratogens and contribute to safety surveillance for other medications. Here, isotretinoin-exposed pregnancy rates were low, but existent, and many pregnancies were terminated. Tretinoin exposure was not associated with a meaningfully elevated risk of losses or malformations as compared with unexposed pregnancies.
Keyphrases
  • preterm birth
  • pregnancy outcomes
  • gestational age
  • public health
  • health insurance
  • big data
  • pregnant women
  • electronic health record
  • affordable care act